Cytek Biosciences
CTKB
₹313.49
Share price
-4.00%
Change (1 day)
-41.23%
Change (1 year)
Categories
Revenue for Cytek Biosciences (CTKB)
Revenue in 2025 (TTM): ₹16.67 Billion
According to Cytek Biosciences's latest financial reports the company's current revenue (TTM 
) is ₹17.15 Billion. In 2024 the company made a revenue of ₹17.19 Billion an increase over the revenue in the year 2023 that were of ₹16.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cytek Biosciences from 2020 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | ₹16.67 B | -3.02% |
| 2024 | ₹17.19 B | 7.02% |
| 2023 | ₹16.06 B | 18.37% |
| 2022 | ₹13.57 B | 42.53% |
| 2021 | ₹9.52 B | 40.26% |
| 2020 | ₹6.78 B |